NCT06234878Completed
REEV SENSE for Gait Analysis in Post-stroke Gait Impairment (SENS-AG)
Validation of REEV SENSE Biomarkers Precision for Gait Analysis in Subjects With Post-stroke Gait Impairment
Source: ClinicalTrials.gov · Last updated 15 Apr 2025
Brief summary (registry, in English)
The purpose of this study is to evaluate the clinical performance of the investigational REEV SENSE gait tracker to measure gait features in subjects with post-stroke gait impairment. REEV SENSE is intended to be used by trained healthcare professionals as a simple procedure adapted to clinical routine. The reference method for performance comparison will be motion capture.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 23 (actual)
- First submitted
- 15 Dec 2023
- Start date
- 8 Jan 2024
- Primary completion date
- 1 Mar 2025
- Lead sponsor
- REEV LLC
- Diseases
- Stroke
- NCT number
- NCT06234878
What you commit to
- Study type: Interventional
- Participants enrolled: 23
- From 8 Jan 2024 to the primary completion date, 1 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Subject unable to give consent.
- Subject unable to understand the tests.
Who the study is looking for
- Post-stroke gait disorder.
- Must be able to walk independently with or without the support of a cane or rollator.
- History of stroke more than six months ago.
- Be 18 years of age or older.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MIT Center for Clinical and Translational Research Coordinator of this site? Confirm its status | Cambridge | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.